Correlation Between Mineralys Therapeutics, and GlycoMimetics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and GlycoMimetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and GlycoMimetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and GlycoMimetics, you can compare the effects of market volatilities on Mineralys Therapeutics, and GlycoMimetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of GlycoMimetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and GlycoMimetics.
Diversification Opportunities for Mineralys Therapeutics, and GlycoMimetics
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Mineralys and GlycoMimetics is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and GlycoMimetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GlycoMimetics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with GlycoMimetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GlycoMimetics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and GlycoMimetics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and GlycoMimetics
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the GlycoMimetics. But the stock apears to be less risky and, when comparing its historical volatility, Mineralys Therapeutics, Common is 7.57 times less risky than GlycoMimetics. The stock trades about -0.06 of its potential returns per unit of risk. The GlycoMimetics is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest 17.00 in GlycoMimetics on August 29, 2024 and sell it today you would earn a total of 15.00 from holding GlycoMimetics or generate 88.24% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. GlycoMimetics
Performance |
| Timeline |
| Mineralys Therapeutics, |
| GlycoMimetics |
Mineralys Therapeutics, and GlycoMimetics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and GlycoMimetics
The main advantage of trading using opposite Mineralys Therapeutics, and GlycoMimetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, GlycoMimetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlycoMimetics will offset losses from the drop in GlycoMimetics' long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals | Mineralys Therapeutics, vs. Seres Therapeutics |
| GlycoMimetics vs. Mineralys Therapeutics, Common | GlycoMimetics vs. Foghorn Therapeutics | GlycoMimetics vs. Inventiva Sa | GlycoMimetics vs. Dyne Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |